Ectonucleotidases in tumor cells and tumor-associated immune cells: An overview

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Bergamin, Letícia Scussel ^a   Braganhol, Elizandra ^b   Zanin, Rafael Fernandes ^c   Edelweiss, Maria Isabel Albano ^d   Battastini, Ana Maria Oliveira ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; ECTONUCLEOTIDASE; ENZYME; NUCLEOSIDE; NUCLEOTIDASE; NUCLEOTIDE; PURINE NUCLEOTIDE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE; ECTOATPASE;

CANCER GROWTH; CELL COMMUNICATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; GLIOMA; HUMAN; HYDROLYSIS; IMMUNOCOMPETENT CELL; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED IMMUNE CELL; TUMOR CELL; ANIMAL; BIOLOGICAL MODEL; DISEASE COURSE; ENZYMOLOGY; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; NEOPLASM; PATHOLOGY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; DISEASE PROGRESSION; HUMANS; LYMPHOCYTES; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 84869059686     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/959848     Document Type: Review

References (109)

1. Zimmermann H., Zebisch M., Sträter N., Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signalling 2012 8 3 437 502 2-s2.0-84861529229 10.1007/s11302-012-9309-4
2. Robson S. C., Sévigny J., Zimmermann H., The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signalling 2006 2 2 409 430 2-s2.0-33846436678 10.1007/s11302-006-9003-5
3. Plesner L., Ecto-ATPases: identities and functions. International Review of Cytology 1995 158 141 214 2-s2.0-0028967657
4. Bigonnesse F., Lévesque S. A., Kukulski F., Lecka J., Robson S. C., Fernandes M. J. G., Sévigny J., Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 2004 43 18 5511 5519 2-s2.0-2442534085 10.1021/bi0362222 (Pubitemid 38620943)
5. Chadwick B. P., Frischauf A. M., The CD39-like gene family: identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster. Genomics 1998 50 3 357 367 2-s2.0-0032526486 10.1006/geno.1998.5317 (Pubitemid 28328756)
6. Heine P., Braun N., Heilbronn A., Zimmermann H., Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. European Journal of Biochemistry 1999 262 1 102 107 2-s2.0-0033563017 10.1046/j.1432-1327.1999.00347.x (Pubitemid 29242615)
7. Kaczmarek E., Koziak K., Sévigny J., Siegel J. B., Anrather J., Beaudoin A. R., Bach F. H., Robson S. C., Identification and characterization of CD39/vascular ATP diphosphohydrolase. The Journal of Biological Chemistry 1996 271 51 33116 33122 2-s2.0-12644288616 10.1074/jbc.271.51.33116 (Pubitemid 27008752)
8. Kegel B., Braun N., Heine P., Maliszewski C. R., Zimmermann H., An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 1997 36 9 1189 1200 2-s2.0-0030721511 10.1016/S0028-3908(97) 00115-9 (Pubitemid 27465607)
9. Smith T. M., Kirley T. L., Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases. Biochimica et Biophysica Acta 1998 1386 1 65 78 2-s2.0-0032575263 10.1016/S0167-4838(98)00063-6 (Pubitemid 29333218)
10. Zimmermann H., Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg's Archives of Pharmacology 2000 362 4-5 299 309 2-s2.0-0033766981 10.1007/s002100000309
11. Bollen M., Gijsbers R., Ceulemans H., Stalmans W., Stefan C., Nucleotide pyrophosphatases/phosphodiesterases on the move. Critical Reviews in Biochemistry and Molecular Biology 2000 35 6 393 432 2-s2.0-0034490045 (Pubitemid 32095990)
12. Goding J. W., Grobben B., Slegers H., Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/ phosphodiesterase family. Biochimica et Biophysica Acta 2003 1638 1 1 19 2-s2.0-0038664247 10.1016/S0925-4439(03)00058-9 (Pubitemid 36577366)
13. Zimmermann H., 5 ′ -Nucleotidase: molecular structure and functional aspects. Biochemical Journal 1992 285 2 345 365 2-s2.0-0026729643
14. Sadej R., Spychala J., Skladanowski A. C., Expression of ecto- 5 ′ -nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Research 2006 16 3 213 222 2-s2.0-33746116078 10.1097/01.cmr. 0000215030.69823.11 (Pubitemid 44085095)
15. Sadej R., Inai K., Rajfur Z., Ostapkowicz A., Kohler J., Skladanowski A. C., Mitchell B. S., Spychala J., Tenascin C interacts with Ecto- 5 ′ -nucleotidase (eN) and regulates adenosine generation in cancer cells. Biochimica et Biophysica Acta 2008 1782 1 35 40 2-s2.0-39149111587 10.1016/j.bbadis.2007.11.001
16. Zhou P., Zhi X., Zhou T., Chen S., Li X., Wang L., Yin L., Shao Z., Ou Z., Overexpression of ecto- 5 ′ -nucleotidase (CD73) promotes T-47D human breast cancer cells invasion and adhesion to extracellular matrix. Cancer Biology and Therapy 2007 6 3 426 431 2-s2.0-34548255860 (Pubitemid 47328312)
17. Bours M. J. L., Swennen E. L. R., Di Virgilio F., Cronstein B. N., Dagnelie P. C., Adenosine 5 ′ -triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacology and Therapeutics 2006 112 2 358 404 2-s2.0-33749261659 10.1016/j.pharmthera.2005.04.013 (Pubitemid 44486409)
18. Coutinho-Silva R., Perfettini J. L., Persechini P. M., Dautry-Varsat A., Ojcius D. M., Modulation of P2Z/P2X7 receptor activity in macrophages infected with Chlamydia psittaci. American Journal of Physiology 2001 280 1 C81 C89 2-s2.0-0035016021
19. Perregaux D., Gabel C. A., Interleukin-1 β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. The Journal of Biological Chemistry 1994 269 21 15195 15203 2-s2.0-0028175838
20. Deaglio S., Robson S. C., Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation and immunity. Advances in Pharmacology 2011 61 301 332 2-s2.0-79955960780 10.1016/B978-0-12-385526-8.00010-2
21. Maliszewski C. R., Delespesse G. J. T., Schoenborn M. A., Armitage R. J., Fanslow W. C., Nakajima T., Baker E., Sutherland G. R., Poindexter K., Birks C., Alpert A., Friend D., Gimpel S. D., Gayle R. B., The CD39 lymphoid cell activation antigen: molecular cloning and structural characterization. The Journal of Immunology 1994 153 8 3574 3583 2-s2.0-0027938206 (Pubitemid 24313861)
22. Koziak K., Sévigny J., Robson S. C., Siegel J. B., Kaczmarek E., Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thrombosis and Haemostasis 1999 82 5 1538 1544 2-s2.0-0032753671 (Pubitemid 29527652)
23. Kumar V., Sharma A., Adenosine: an endogenous modulator of innate immune system with therapeutic potential. European Journal of Pharmacology 2009 616 13 7 15 2-s2.0-67651161862 10.1016/j.ejphar.2009.05.005
24. Zanin R. F., Braganhol E., Bergamin L. S., Campesato L. F. I., Filho A. Z., Moreira J. C. F., Morrone F. B., Sévigny J., Schetinger M. R. C., de Souza Wyse A. T., Battastini A. M. O., Differential macrophage activation alters the expression profile of NTPDase and Ecto- 5 ′ -nucleotidase. PLoS ONE 2012 7 2 e31205 2-s2.0-84856873768 10.1371/journal.pone.0031205
25. Kukulski F., Bahrami F., Ben Yebdri F., Lecka J., Martín- Satué M., Lévesque S. A., Sévigny J., NTPDase1 controls IL-8 production by human neutrophils. The Journal of Immunology 2011 187 2 644 653 2-s2.0-79960507785 10.4049/jimmunol.1002680
26. Lévesque S. A., Kukulski F., Enjyoji K., Robson S. C., Sévigny J., NTPDase1 governs P2X7-dependent functions in murine macrophages. European Journal of Immunology 2010 40 5 1473 1485 2-s2.0-77951715173 10.1002/eji.200939741
27. Dombrowski K. E., Trevillyan J. M., Cone J. C., Lu Y., Phillips C. A., Identification and partial characterization of an EctoATPase expressed by human natural killer cells. Biochemistry 1993 32 26 6515 6522 2-s2.0-0027197470 (Pubitemid 23217120)
28. Dombrowski K. E., Ke Y., Thompson L. F., Kapp J. A., Antigen recognition by CTL is dependent upon ectoATPase activity. The Journal of Immunology 1995 154 12 6227 6237 2-s2.0-0029006862
29. Dombrowski K. E., Cone J. C., Bjorndahl J. M., Phillips C. A., Irreversible inhibition of human natural killer cell natural cytotoxicity by modification of the extracellular membrane by the adenine nucleotide analog 5'-p-(fluorosulfonyl)benzoyl adenosine. Cellular Immunology 1995 160 2 199 204 2-s2.0-0028804403 10.1016/0008-8749(95)80028-H
30. Langston H. P., Ke Y., Gewirtz A. T., Dombrowski K. E., Kapp J. A., Secretion of IL-2 and IFN- γ but not IL-4, by antigen-specific T cells requires extracellular ATP. The Journal of Immunology 2003 170 6 2962 2970 2-s2.0-0037443419 (Pubitemid 36302168)
31. Tsukamoto H., Chernogorova P., Ayata K., Gerlach U. V., Rughani A., Ritchey J. W., Ganesan J., Follo M., Zeiser R., Thompson L. F., Idzko M., Deficiency of CD73/ecto- 5 ′ -nucleotidase in mice enhances acute graft-versus-host disease. Blood 2012 119 19 4554 4564 2-s2.0-84860538096
32. Mandapathil M., Szczepanski M. J., Szajnik M., Ren J., Lenzner D. E., Jackson E. K., Gorelik E., Lang S., Johnson J. T., Whiteside T. L., Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clinical Cancer Research 2009 15 20 6348 6357 2-s2.0-70350231926 10.1158/1078-0432.CCR-09-1143
33. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007 110 4 1225 1232 2-s2.0-34547098277 10.1182/blood-2006-12-064527 (Pubitemid 47281420)
34. Deaglio S., Dwyer K. M., Gao W., Friedman D., Usheva A., Erat A., Chen J. F., Enjyoji K., Linden J., Oukka M., Kuchroo V. K., Strom T. B., Robson S. C., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Journal of Experimental Medicine 2007 204 6 1257 1265 2-s2.0-34250351459 10.1084/jem.20062512 (Pubitemid 46919862)
35. Miyara M., Sakaguchi S., Natural regulatory T cells: mechanisms of suppression. Trends in Molecular Medicine 2007 13 3 108 116 2-s2.0-33847415066 10.1016/j.molmed.2007.01.003 (Pubitemid 46341958)
36. Whiteside T. L., Mandapathil M., Schuler P., The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). Current Medicinal Chemistry 2011 18 34 5217 5223 2-s2.0-82255161799 10.2174/092986711798184334
37. Sauer A. V., Brigida I., Carriglio N., Hernandez R. J., Scaramuzza S., Clavenna D., Sanvito F., Poliani P. L., Gagliani N., Carlucci F., Tabucchi A., Roncarolo M. G., Traggiai E., Villa A., Aiuti A., Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID. Blood 2012 119 6 1428 1439 2-s2.0-84856838658 10.1182/blood-2011-07-366781
38. + T regulatory cells correlates with progression of HBV infection. BMC Immunology 2012 13, article 17 2-s2.0-84859482444 10.1186/1471-2172-13-17
39. Loza M. J., Shane Anderson A., O'Rourke K. S., Wood J., Khan I. U., T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cellular Immunology 2011 271 1 110 117 2-s2.0-79960140617 10.1016/j.cellimm.2011.06.010
40. Hyman M. C., Petrovic-Djergovic D., Visovatti S. H., Liao H., Yanamadala S., Bouïs D., Su E. J., Lawrence D. A., Broekman M. J., Marcus A. J., Pinsky D. J., Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. The Journal of Clinical Investigation 2009 119 5 1136 1149 2-s2.0-66449110381 10.1172/JCI36433
41. Pelegrin P., Surprenant A., Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. The EMBO Journal 2009 28 14 2114 2127 2-s2.0-67651172779 10.1038/emboj.2009.163
42. La Sala A., Ferrari D., Corinti S., Cavani A., Di Virgilio F., Girolomoni G., Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. The Journal of Immunology 2001 166 3 1611 1617 2-s2.0-0035253431 (Pubitemid 32114641)
43. Mizumoto N., Kumamoto T., Robson S. C., Sévigny J., Matsue H., Enjyoji K., Takashima A., CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nature Medicine 2002 8 4 358 365 2-s2.0-0036102125 10.1038/nm0402-358 (Pubitemid 34407030)
44. Corriden R., Chen Y., Inoue Y., Beldi G., Robson S. C., Insel P. A., Junger W. G., Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. The Journal of Biological Chemistry 2008 283 42 28480 28486 2-s2.0-57649131049 10.1074/jbc.M800039200
45. Louis D. N., The p53 gene and protein in human brain tumors. Journal of Neuropathology and Experimental Neurology 1994 53 1 11 21 2-s2.0-0028123442 (Pubitemid 24022082)
46. von Deimling A., Louis D. N., Wiestler O. D., Molecular pathways in the formation of gliomas. Glia 1995 15 3 328 338 2-s2.0-0029397626
47. Maher E. A., Furnari F. B., Bachoo R. M., Rowitch D. H., Louis D. N., Cavenee W. K., DePinho R. A., Malignant glioma: genetics and biology of a grave matter. Genes and Development 2001 15 11 1311 1333 2-s2.0-0034987702 10.1101/gad.891601 (Pubitemid 32524640)
48. Shapiro J. R., Genetics of brain neoplasms. Current Neurology and Neuroscience Reports 2001 1 3 217 224 2-s2.0-0035353018
49. Mantovani A., Cancer: inflaming metastasis. Nature 2009 457 7225 36 37 2-s2.0-58149231380 10.1038/457036b
50. Takano T., Lin J. H. C., Arcuino G., Gao Q., Yang J., Nedergaard M., Glutamate release promotes growth of malignant gliomas. Nature Medicine 2001 7 9 1010 1015 2-s2.0-0034800265 10.1038/nm0901-1010 (Pubitemid 32937380)
51. Pellegatti P., Raffaghello L., Bianchi G., Piccardi F., Pistoia V., Di Virgilio F., Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE 2008 3 7 2-s2.0-50249085890 10.1371/journal.pone.0002599 e2599
52. Melani A., De Micheli E., Pinna G., Alfieri A., Corte L. D., Pedata F., Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study. Neuroscience Letters 2003 346 1-2 93 96 2-s2.0-0038383770 10.1016/S0304-3940(03)00596-2 (Pubitemid 36792201)
53. Ryu J. K., Choi H. B., Hatori K., Heisel R. L., Pelech S. L., McLarnon J. G., Kim S. U., Adenosine triphosphate induces proliferation of human neural stem cells: role of calcium and p70 ribosomal protein S6 kinase. Journal of Neuroscience Research 2003 72 3 352 362 2-s2.0-0242432424 10.1002/jnr.10507 (Pubitemid 36504704)
54. Lenz G., Gottfried C., Zhijun L., Avruch J., Rodnight R., Wie-Jia N., Kang Y., Neary J. T., P(2Y) purinoceptor subtypes recruit different Mek activators in astrocytes. British Journal of Pharmacology 2000 129 5 927 936 2-s2.0-0008488424 (Pubitemid 30142905)
55. Neary J. T., Kang Y., Willoughby K. A., Ellis E. F., Activation of extracellular signal-regulated kinase by stretch-induced injury in astrocytes involves extracellular ATP and P2 purinergic receptors. Journal of Neuroscience 2003 23 6 2348 2356 2-s2.0-0037444676 (Pubitemid 36368923)
56. Spychala J., Tumor-promoting functions of adenosine. Pharmacology and Therapeutics 2000 87 2-3 161 173 2-s2.0-0033796779 10.1016/S0163-7258(00)00053-X
57. 2A adenosine receptor protects tumors from antitumor T cells. Proceedings of the National Academy of Sciences of the United States of America 2006 103 35 13132 13137 2-s2.0-33748357735 10.1073/pnas.0605251103 (Pubitemid 44338928)
58. Lazarowski E. R., Boucher R. C., Harden T. K., Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. The Journal of Biological Chemistry 2000 275 40 31061 31068 2-s2.0-0034613299
59. Abbracchio M. P., Burnstock G., Boeynaems J. M., Barnard E. A., Boyer J. L., Kennedy C., Knight G. E., Fumagalli M., Gachet C., Jacobson K. A., Weisman G. A., International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacological Reviews 2006 58 3 281 341 2-s2.0-33745742679 10.1124/pr.58.3.3 (Pubitemid 44394905)
60. Okada S. F., Nicholas R. A., Kreda S. M., Lazarowski E. R., Boucher R. C., Physiological regulation of ATP release at the apical surface of human airway epithelia. The Journal of Biological Chemistry 2006 281 32 22992 23002 2-s2.0-33747356489 10.1074/jbc.M603019200
61. Burnstock G., Purinergic signalling: its unpopular beginning, its acceptance and its exciting future. BioEssays 2012 34 3 218 225 2-s2.0-84857045446 10.1002/bies.201100130
62. Häusler S. F. M., Montalbán del Barrio I., Strohschein J., Anoop Chandran P., Engel J. B., Hönig A., Ossadnik M., Horn E., Fischer B., Krockenberger M., Heuer S., Seida A. A., Junker M., Kneitz H., Kloor D., Klotz K. N., Dietl J., Wischhusen J., Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunology, Immunotherapy 2011 60 10 1405 1418 2-s2.0-79957650192 10.1007/s00262-011-1040-4
63. Buffon A., Wink M. R., Ribeiro B. V., Casali E. A., Libermann T. A., Zerbini L. F., Robson S. C., Sarkis J. J. F., NTPDase and 5 ′ ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor. Biochimica et Biophysica Acta 2007 1770 8 1259 1265 2-s2.0-34347266911 10.1016/j.bbagen.2007.05.004 (Pubitemid 47007733)
64. Dzhandzhugazyan K. N., Kirkin A. F., Thor Straten P., Zeuthen J., Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Letters 1998 430 3 227 230 2-s2.0-0032479195 10.1016/S0014-5793(98)00603-6 (Pubitemid 28337918)
65. Künzli B. M., Bernlochner M. I., Rath S., Käser S., Csizmadia E., Enjyoji K., Cowan P., d'Apice A., Dwyer K., Rosenberg R., Perren A., Friess H., Maurer C. A., Robson S. C., Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signalling 2011 7 2 231 241 2-s2.0-79961011452 10.1007/s11302-011-9228-9
66. Morrone F. B., Oliveira D. L., Gamermann P., Stella J., Wofchuk S., Wink M. R., Meurer L., Edelweiss M. I. A., Lenz G., Battastini A. M. O., In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. BMC Cancer 2006 6, article 226 2-s2.0-33749602019 10.1186/1471-2407-6-226 (Pubitemid 44541832)
67. Stella J., Bavaresco L., Braganhol E., Rockenbach L., Farias P. F., Wink M. R., Azambuja A. A., Barrios C. H., Morrone F. B., Oliveira Battastini A. M., Differential ectonucleotidase expression in human bladder cancer cell lines. Urologic Oncology 2010 28 3 260 267 2-s2.0-77951623666 10.1016/j.urolonc.2009. 01.035
68. Jackson S. W., Hoshi T., Wu Y., Sun X., Enjyoji K., Cszimadia E., Sundberg C., Robson S. C., Disordered purinergic signaling inhibits pathological angiogenesis in Cd39/Entpd1-null mice. American Journal of Pathology 2007 171 4 1395 1404 2-s2.0-35348839497 10.2353/ajpath.2007.070190 (Pubitemid 47582911)
69. + regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010 139 3 1030 1040 2-s2.0-77956134431 10.1053/j.gastro.2010.05.007
70. Feng L., Sun X., Csizmadia E., Han L., Bian S., Murakami T., Wang X., Robson S. C., Wu Y., Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate. Neoplasia 2011 13 3 206 216 2-s2.0-79952414321 10.1593/neo.101332
71. +-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness. The Journal of Immunology 2009 183 10 6157 6166 2-s2.0-77954229218 10.4049/jimmunol.0900475
72. Jin D., Fan J., Wang L., Thompson L. F., Liu A., Daniel B. J., Shin T., Curiel T. J., Zhang B., CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Research 2010 70 6 2245 2255 2-s2.0-77950231071 10.1158/0008-5472.CAN-09-3109
73. Wang L., Fan J., Thompson L. F., Zhang Y., Shin T., Curiel T. J., Zhang B., CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. The Journal of Clinical Investigation 2011 121 6 2371 2382 2-s2.0-79957921286 10.1172/JCI45559
74. Bavaresco L., Bernardi A., Braganhol E., Cappellari A. R., Rockenbach L., Farias P. F., Wink M. R., Delgado-Caedo A., Battastini A. M. O., The role of ecto- 5 ′ -nucleotidase/CD73 in glioma cell line proliferation. Molecular and Cellular Biochemistry 2008 319 1-2 61 68 2-s2.0-55649124110 10.1007/s11010-008-9877-3
75. Sadej R., Spychala J., Skladanowski A. C., Expression of ecto-5 5 ′ -nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Research 2006 16 3 213 222 2-s2.0-33746116078 10.1097/01.cmr. 0000215030.69823.11 (Pubitemid 44085095)
76. Cho S. Y., Polster J., Engles J. M., Hilton J., Abraham E. H., Wahl R. L., In vitro evaluation of adenosine 5 ′ -monophosphate as an imaging agent of tumor metabolism. Journal of Nuclear Medicine 2006 47 5 837 845 2-s2.0-33745543989 (Pubitemid 46768448)
77. Kondo T., Nakazawa T., Murata S. I., Katoh R., Expression of CD73 and its ecto- 5 ′ -nucleotidase activity are elevated in papillary thyroid carcinomas. Histopathology 2006 48 5 612 614 2-s2.0-33645396217 10.1111/j.1365-2559.2005.02277.x
78. Fukuda K., Sakakura C., Miyagawa K., Kuriu Y., Kin S., Nakase Y., Hagiwara A., Mitsufuji S., Okazaki Y., Hayashizaki Y., Yamagishi H., Differential gene expression profiles of radio resistant oesophageal cancer cell lines established by continuous fractionated irradiation. British Journal of Cancer 2004 91 8 1543 1550 2-s2.0-7944225835 10.1038/sj.bjc.6602187 (Pubitemid 39486360)
79. Hastie C., Saxton M., Akpan A., Cramer R., Masters J. R., Naaby-Hansen S., Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells. Oncogene 2005 24 38 5905 5913 2-s2.0-26944496510 10.1038/sj.onc.1208747 (Pubitemid 43080082)
80. Spychala J., Lazarowski E., Ostapkowicz A., Ayscue L. H., Jin A., Mitchell B. S., Role of estrogen receptor in the regulation of ecto- 5 ′ -nucleotidase and adenosine in breast cancer. Clinical Cancer Research 2004 10 2 708 717 2-s2.0-0842311602 10.1158/1078-0432.CCR-0811-03 (Pubitemid 38174010)
81. Wang L., Zhou X., Zhou T., Ma D., Chen S., Zhi X., Yin L., Shao Z., Ou Z., Zhou P., Ecto- 5 ′ -nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. Journal of Cancer Research and Clinical Oncology 2008 134 3 365 372 2-s2.0-38649133357 10.1007/s00432-007-0292-z (Pubitemid 351170058)
82. Singh Ghalaut V., Dahiya K., Ghalaut P. S., Batra S., Dhankhar R., Lymphocytic ecto 5 ′ -nucleotidase (ecto- 5 ′ NT) levels in acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Clinica Chimica Acta 2006 364 1-2 359 360 2-s2.0-31044449620 10.1016/j.cca.2005.07.031 (Pubitemid 43120669)
83. Stagg J., Divisekera U., McLaughlin N., Sharkey J., Pommey S., Denoyer D., Dwyer K. M., Smyth M. J., Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proceedings of the National Academy of Sciences of the United States of America 2010 107 4 1547 1552 2-s2.0-75949112218 10.1073/pnas.0908801107
84. Zhi X., Chen S., Zhou P., Shao Z., Wang L., Ou Z., Yin L., RNA interference of ecto- 5 ′ -nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clinical and Experimental Metastasis 2007 24 6 439 448 2-s2.0-34548435229 10.1007/s10585-007-9081-y (Pubitemid 47367686)
85. Yegutkin G. G., Marttila-Ichihara F., Karikoski M., Niemelä J., Laurila J. P., Elima K., Jalkanen S., Salmi M., Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. European Journal of Immunology 2011 41 5 1231 1241 2-s2.0-79955153842 10.1002/eji.201041292
86. Stagg J., Divisekera U., Duret H., Sparwasser T., Teng M. W. L., Darcy P. K., Smyth M. J., CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Research 2011 71 8 2892 2900 2-s2.0-79954576658 10.1158/0008-5472.CAN-10-4246
87. Stagg J., Beavis P. A., Divisekera U., Liu M. C. P., Möller A., Darcy P. K., Smyth M. J., CD73-Deficient mice are resistant to carcinogenesis. Cancer Research 2012 72 9 2190 2196 2-s2.0-84860382842
88. Morrone F. B., Jacques-Silva M. C., Horn A. P., Bernardi A., Schwartsmann G., Rodnight R., Lenz G., Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines. Journal of Neuro-Oncology 2003 64 3 211 218 2-s2.0-0141459429 10.1023/A:1025699932270 (Pubitemid 37203461)
89. Morrone F. B., Horn A. P., Stella J., Spiller F., Sarkis J. J. F., Salbego C. G., Lenz G., Battastini A. M. O., Increased resistance of glioma cell lines to extracellular ATP cytotoxicity. Journal of Neuro-Oncology 2005 71 2 135 140 2-s2.0-20144366139 10.1007/s11060-004-1383-1 (Pubitemid 40796294)
90. Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., Burnstock G., Volonté C., P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 2002 42 4 489 501 2-s2.0-0036223122 10.1016/S0028-3908(01)00197-6 (Pubitemid 34304242)
91. Wink M. R., Lenz G., Braganhol E., Tamajusuku A. S. K., Schwartsmann G., Sarkis J. J. F., Battastini A. M. O., Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Letters 2003 198 2 211 218 2-s2.0-0142087773 10.1016/S0304-3835(03)00308-2 (Pubitemid 37297794)
92. Braganhol E., Morrone F. B., Bernardi A., Huppes D., Meurer L., Edelweiss M. I. A., Lenz G., Wink M. R., Robson S. C., Battastini A. M. O., Selective NTPDase2 expression modulates in vivo rat glioma growth. Cancer Science 2009 100 8 1434 1442 2-s2.0-67650680894 10.1111/j.1349-7006.2009.01219.x
93. Braganhol E., Zanin R. F., Bernardi A., Bergamin L. S., Cappellari A. R., Campesato L. F., Morrone F. B., Campos M. M., Calixto J. B., Edelweiss M. I. A., Wink M. R., Sévigny J., Robson S. C., Battastini A. M. O., Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury. Purinergic Signalling 2012 8 2 235 243 2-s2.0-84860999144 10.1007/s11302-011-9276-1
94. Grobben B., Anciaux K., Roymans D., Stefan C., Bollen M., Esmans E. L., Slegers H., An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. Journal of Neurochemistry 1999 72 2 826 834 2-s2.0-0032902151 10.1046/j.1471-4159.1999. 0720826.x (Pubitemid 29055249)
95. Aerts I., Martin J. J., Deyn P. P. D., Van Ginniken C., Van Ostade X., Kockx M., Dua G., Slegers H., The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade. Clinical Neurology and Neurosurgery 2011 113 3 224 229 2-s2.0-79952282374 10.1016/j.clineuro.2010.11.018
96. Komohara Y., Ohnishi K., Kuratsu J., Takeya M., Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. Journal of Pathology 2008 216 1 15 24 2-s2.0-50249144131 10.1002/path.2370
97. Mora R., Abschuetz A., Kees T., Dokic I., Joschko N., Kleber S., Geibig R., Mosconi E., Zentgraf H., Martin-Villalba A., Régnier-Vigouroux A., TNF- α-and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia. Glia 2009 57 5 561 581 2-s2.0-65249134734 10.1002/glia.20785
98. Watters J. J., Schartner J. M., Badie B., Microglia function in brain tumors. Journal of Neuroscience Research 2005 81 3 447 455 2-s2.0-25444488717 10.1002/jnr.20485 (Pubitemid 41359299)
99. Jantaratnotai N., Choi H. B., McLarnon J. G., ATP stimulates chemokine production via a store-operated calcium entry pathway in C6 glioma cells. BMC Cancer 2009 9, article 442 2-s2.0-74549117714 10.1186/1471-2407-9-442
100. Sica A., Bronte V., Altered macrophage differentiation and immune dysfunction in tumor development. The Journal of Clinical Investigation 2007 117 5 1155 1166 2-s2.0-34248172324 10.1172/JCI31422 (Pubitemid 46718400)
101. Solinas G., Germano G., Mantovani A., Allavena P., Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. Journal of Leukocyte Biology 2009 86 5 1065 1073 2-s2.0-70350728931 10.1189/jlb.0609385
102. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow? The Lancet 2001 357 9255 539 545 2-s2.0-0035901090 10.1016/S0140-6736(00)04046-0 (Pubitemid 32173595)
103. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
104. Sanai N., Alvarez-Buylla A., Berger M. S., Mechanisms of disease: neural stem cells and the origin of gliomas. The New England Journal of Medicine 2005 353 8 811 822 2-s2.0-23944445606 10.1056/NEJMra043666 (Pubitemid 41215490)
105. Singh S. K., Clarke I. D., Hide T., Dirks P. B., Cancer stem cells in nervous system tumors. Oncogene 2004 23 43 7267 7273 2-s2.0-6044221204 10.1038/sj.onc.1207946 (Pubitemid 39382160)
106. Ohkubo S., Nagata K., Nakahata N., Adenosine uptake-dependent C6 cell growth inhibition. European Journal of Pharmacology 2007 577 13 35 43 2-s2.0-35448940953 10.1016/j.ejphar.2007.08.025 (Pubitemid 47632522)
107. Zhang B., CD73 promotes tumor growth and metastasis. Oncoimmunology 2012 1 1 67 70
108. Gessi S., Sacchetto V., Fogli E., Merighi S., Varani K., Baraldi P. G., Tabrizi M. A., Leung E., Maclennan S., Borea P. A., Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors. Biochemical Pharmacology 2010 79 10 1483 1495 2-s2.0-77649181282 10.1016/j.bcp.2010.01.009
109. Cappellari A. R., Vasques G. J., Bavaresco L., Braganhol E., Battastini A. M. O., Involvement of ecto- 5 ′ -nucleotidase/CD73 in U138MG glioma cell adhesion. Molecular and Cellular Biochemistry 2012 359 1-2 315 322 2-s2.0-83555164934 10.1007/s11010-011-1025-9